Hansen Medical (HNSN) Appoints Former Biogen COO Rohn to Board
Tweet
Share
E-mailGet Alerts HNSN Hot Sheet
Join SI Premium – FREE
Hansen Medical, Inc. (Nasdaq: HNSN), announced William R. Rohn has been appointed as a Director and elected to chair the Compensation Committee, effective immediately. The appointment increases board membership to eight. Mr. Rohn brings to the board significant experience from his over 40 years of executive management in the healthcare industry.
Rohn has extensive healthcare experience, having previously served as Chief Operating Officer of Biogen Idec (Nasdaq: BIIB).
Rohn has extensive healthcare experience, having previously served as Chief Operating Officer of Biogen Idec (Nasdaq: BIIB).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kite Realty Group names new VP of capital markets and IR
- Ethan Allen declares $3-per-share special cash dividend
- AVAX One CFO departs, controller promoted to chief accounting officer
Create E-mail Alert Related Categories
Corporate News, Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
